Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (CB-SCs) in stem cell educator therapy: phase I/II clinical trial
2013 · BMC Medicine · 82 citations
https://doi.org/10.1186/1741-7015-11-160